Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266

Watchlist Manager
Suzhou Zelgen Biopharmaceuticals Co Ltd Logo
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Watchlist
Price: 67.99 CNY -0.89% Market Closed
Market Cap: 18B CNY
Have any thoughts about
Suzhou Zelgen Biopharmaceuticals Co Ltd?
Write Note

Suzhou Zelgen Biopharmaceuticals Co Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Suzhou Zelgen Biopharmaceuticals Co Ltd
Research & Development Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Research & Development
-ÂĄ458.9m
CAGR 3-Years
-19%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Research & Development
-ÂĄ12.5B
CAGR 3-Years
-13%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Research & Development
-ÂĄ1.1B
CAGR 3-Years
-54%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Research & Development
-ÂĄ192.9m
CAGR 3-Years
-14%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Research & Development
-ÂĄ992.9m
CAGR 3-Years
-41%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Research & Development
-ÂĄ232.4m
CAGR 3-Years
-59%
CAGR 5-Years
-49%
CAGR 10-Years
N/A

See Also

What is Suzhou Zelgen Biopharmaceuticals Co Ltd's Research & Development?
Research & Development
-458.9m CNY

Based on the financial report for Dec 31, 2023, Suzhou Zelgen Biopharmaceuticals Co Ltd's Research & Development amounts to -458.9m CNY.

What is Suzhou Zelgen Biopharmaceuticals Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-29%

Over the last year, the Research & Development growth was 0%. The average annual Research & Development growth rates for Suzhou Zelgen Biopharmaceuticals Co Ltd have been -19% over the past three years , -29% over the past five years .

Back to Top